Obsidian Therapeutics, Inc. OBX
Set alert
14.43 USD -0.36 -2.43%
At close
14.00 -0.43 -2.98%
Pre-market · Nov 3, 5:42 AM ET
13.48 Day range 14.92
11.52 52-week range 49.97
- YTD
- -17.54%
- 1 year
- -17.54%
- Open
- 14.62
- Prev close
- 14.79
- Mkt cap
- 891.38M
- Vol
- 526.05K
- Avg vol
- 395.13K
- EPS
- -1.63
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 13.48
- High
- 14.92
- Forward P/E
- -7.98
- Beta
- 2.60
- Short ratio
- 0.69
- Inst. own
- 27.36%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 31, 2025
- 50-d avg
- 19.99
- 200-d avg
- 19.99
- 1y target
- 39.00
1D chart
Signals (33)
| Name | Time | Ago |
|---|---|---|
| MACD: Buy Signal | 2:31 PM | 17 hours ago |
| RSI: Oversold | 2:23 PM | 18 hours ago |
| SMA: Bearish | 2:00 PM | 18 hours ago |
| MACD: Sell Signal | 1:47 PM | 18 hours ago |
| MACD: Buy Signal | 1:36 PM | 18 hours ago |
| RSI: Overbought | 1:36 PM | 18 hours ago |
| MACD: Sell Signal | 1:20 PM | 19 hours ago |
| RSI: Overbought | 1:06 PM | 19 hours ago |
| RSI: Overbought | 12:59 PM | 19 hours ago |
| MACD: Buy Signal | 12:53 PM | 19 hours ago |
| RSI: Overbought | 12:53 PM | 19 hours ago |
| MACD: Sell Signal | 12:37 PM | 19 hours ago |
| SMA: Bullish | 12:18 PM | 20 hours ago |
| SMA: Bearish | 12:13 PM | 20 hours ago |
| SMA: Bullish | 12:09 PM | 20 hours ago |
| MACD: Buy Signal | 12:04 PM | 20 hours ago |
| MACD: Sell Signal | 11:54 AM | 20 hours ago |
| RSI: Oversold | 11:51 AM | 20 hours ago |
| MACD: Buy Signal | 11:38 AM | 20 hours ago |
| SMA: Bearish | 11:20 AM | 21 hours ago |
Newest 20 of 33.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 39.00 +170.3% upside
Now 14.43
- Target (low)
- 32.00
- Target (mean)
- 39.00
- Target (high)
- 43.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
- Strong buy1
- Buy4
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.44 | -0.47 – -0.41 | 0.00 | 0.0% | 0 | 0.0% | 2 |
| Next quarter | -0.555 | -0.61 – -0.50 | 0.00 | 0.0% | 0 | 0.0% | 2 |
| Current year | -2.24 | -2.62 – -1.85 | -2,057.27 | +99.9% | 0 | 0.0% | 2 |
| Next year | -2.79 | -3.85 – -2.13 | -2.24 | -24.8% | 0 | 0.0% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 22, 2026 | Leerink Partners | Initiated | — | Outperform |
| Sep 9, 2026 | William Blair | Initiated | — | Outperform |
| Aug 18, 2026 | LifeSci Capital | Initiated | — | Outperform |
| Aug 5, 2026 | Piper Sandler | Initiated | — | Overweight |